Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -69.54M
March 31, 2026 -71.30M
December 31, 2025 -41.93M
September 30, 2025 -45.76M
June 30, 2025 -66.08M
March 31, 2025 -79.29M
December 31, 2024 -83.39M
September 30, 2024 -55.26M
June 30, 2024 -99.08M
March 31, 2024 -37.22M
December 31, 2023 -82.80M
September 30, 2023 -80.16M
June 30, 2023 -100.53M
March 31, 2023 -81.96M
December 31, 2022 -100.75M
September 30, 2022 -99.89M
Date Value
June 30, 2022 -134.97M
March 31, 2022 -51.32M
December 31, 2021 -101.61M
September 30, 2021 -75.29M
June 30, 2021 -81.27M
March 31, 2021 -25.88M
December 31, 2020 -66.50M
September 30, 2020 -17.84M
June 30, 2020 -32.87M
March 31, 2020 -40.77M
December 31, 2019 -37.43M
September 30, 2019 -7.097M
June 30, 2019 -16.88M
March 31, 2019 -7.008M
December 31, 2018 -29.47M
September 30, 2018 -27.96M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Natera, Inc. -8.636M
Quest Diagnostics, Inc. 459.00M
Labcorp Holdings, Inc. 313.90M
OPKO Health, Inc. -46.50M
Psychemedics Corp. --